MEDICENNA BY THE NUMBERS

1:

Focused on ONE Target: the Interleukin-4 Receptor (IL4R)

20:

Number of Caners Known to Over-Express the IL4R1

1 Million:

Annual Incidence of IL4R Positive Cancers 2

30 Million:

Non-Dilutive Grant and Equity

40:

Number of Patents Filed or Issued

250,000:

Annual Incidence of Glioblastoma and Metastatic Brain Cancer 3

10,000:

Brain Tumor Patients that can be treated with 1 Gram of MDNA55 4

2 Billion:

Potential Market of MDNA55 Market for Brain Cancer ($US)

:

HOPE

Top